Research & Development

Biopharma Sustainability for Food & Health iBETXplore Program

Our Biopharma R&D labs and support units work on the latest technologies and platforms to advance the development of Biopharmaceuticals, ATMPs and Vaccines.

Core Areas

Bioengineering for Cell-based Therapies

Bridging bioprocess engineering and stem cell biology to accelerate the development of advanced cell therapies.

Advanced Technologies for Gene Therapy Products

Bespoke R&D solutions in virus-based biopharmaceuticals – from gene to bioprocess development

Vaccines Bioprocess Engineering

Integrating multidisciplinary cutting-edge technologies to create innovative bioprocesses for production of vaccines.

Advanced Cell Models for Drug Discovery and Translational Research

Leveraging ATMP development with advanced human cell models reconstructing disease microenvironments

Translational Immunology

Developing tools and strategies to test and potentiate the effectiveness of ATMPS and advanced immunotherapies.

Protein Biophysics for Drug Discovery

Our Research and Development projects cover Gene-to-Structure initiatives, coupled with molecular interactions studies for small molecule ligands and antibodies.

Support Units

Late-Stage R&D and Bioproduction Unit

Strong base of competences in late-stage R&D, scale-up and technology transfer for complex biopharmaceuticals production.

cGMP Analytical Services Unit (ASU)

Advanced bioanalytics to support iBET’s R&D activities and GMP (Good Manufacturing Practices) analytical services for Pharmaceutical and Biotech companies.

Mass Spectrometry Unit

Advanced Mass Spectrometry-based R&D services to support our partners in bioprocess understanding & development and in-depth characterization of biologics

Data Analytics Center (DAC)

Bridging data management, data science and advanced analytics to leverage knowledge, value creation and support digital transformation at iBET.

iBETXplore Innovation Program

Explore Details